Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Albumin and Captopril

supplement:

Albumin

Research Papers that Mention the Interaction

CONCLUSIONS Ca topril therapy si gnificantly impeded progression to clinical proteinuria and prevented the increase in alb umin ex cretion rate in nonhypertensive patients with insulin-dependent diabetes mellitus and persistent microalbuminuria.
JAMA  •  1994  |  View Paper
Albumin excretion rate decreased significantly during captopril therapy (baseline 78 +/- 114 micrograms/min; mean of monthly measurements 38 +/- 55 micrograms/min vs placebo 78 +/- 140 micrograms/min; p less than 0.001).
The Journal of pediatrics  •  1990  |  View Paper
In vitro and in vivo, captopril formed disulfide bonds with albumin and other proteins.
Drug metabolism reviews  •  1984  |  View Paper
Treatment with either captopril , enalapril or lisinopril reduced albumin excretion rate in comparison with control patients.
The Cochrane database of systematic reviews  •  2007  |  View Paper
Treatment with either captopril , enalapril or lisinopril reduced albumin excretion rate in comparison with control patients.
The Cochrane database of systematic reviews  •  2001  |  View Paper
Treatment with either captopril , enalapril or lisinopril reduced albumin excretion rate in comparison with control patients.
The Cochrane database of systematic reviews  •  2000  |  View Paper
In contrast, captopril rapidly associates with albumin to form noncovalent albumin-captopril complexes.
Biochemical pharmacology  •  1993  |  View Paper
Captopril treatment equally attenuated cerebral herniation and hematoma expansion but was less effective in stopping albumin extravasation and allowed cerebrum volume to increase to post-stroke levels after 60 days of treatment.
Vascular pharmacology  •  2018  |  View Paper
The combination of irbesartan and captopril induced further reductions in blood pressure (140+/-3 mmHg) and albumin excretion rates (4.0x//1.5 mg/day).
Clinical science  •  2001  |  View Paper